Drugs / ABT-143
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00808678 | Dec 2008 → Jan 2009 | — | AstraZeneca | Completed | No outcome recorded |
| Phase 1 | NCT00826358 | Nov 2008 | — | AstraZeneca | Completed | No outcome recorded |
| Phase 1 | NCT00681395 | May → Aug 2008 | — | AstraZeneca | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ABT-143 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00826358 ↗ |